Not Yet Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
NCT07684235
- Conditions
- Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +5 more
- Locations
-
Not specified